Comparison of two methods for the analysis of [18F]6-fluoro-L-m- tyrosine PET data

NeuroImage

Volumn 23, Issue 1, 2004, Pages 358-363

  Eberling, Jamie L ^a,b,d   Pivirotto, Phillip ^c   Bringas, John ^c   Bankiewicz, Krys S ^c  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Berkeley CA 94720 ^*  (United States)

Author keywords

FMT; Input function; Parkinson disease; PET

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 6 FLUORO 3 TYROSINE F 18; DOPAMINE; TRACER; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN MAPPING; BRAIN SCINTISCANNING; CEREBELLUM; CLINICAL PRACTICE; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; INTERMETHOD COMPARISON; MONKEY; NEUROIMAGING; NONHUMAN; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRESYNAPTIC NERVE; PRIMATE; PRIORITY JOURNAL; PUTAMEN; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE;

ANIMALS; CEREBELLUM; CORPUS STRIATUM; DOMINANCE, CEREBRAL; DOPAMINE; FLUORINE RADIOISOTOPES; IMAGE PROCESSING, COMPUTER-ASSISTED; MACACA MULATTA; PARKINSONIAN DISORDERS; POSITRON-EMISSION TOMOGRAPHY; PRESYNAPTIC TERMINALS; PUTAMEN; STATISTICS; TYROSINE;

EID: 4344636767     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2004.06.005     Document Type: Article

References (14)

1. Dhawan V., Ma Y., et al. Comparative analysis of striatal FDOPA uptake in Parkinson's disease: ratio method versus graphical approach. J. Nucl. Med. 43:2002;1324-1330
2. Eberling J.L., Bankiewicz K.S., et al. PET studies of functional compensation in a primate model of Parkinson's disease. NeuroReport. 8:1997;2727-2733
3. Eberling J.L., Jagust W.J., et al. A novel MPTP primate model of Parkinson's disease: neurochemical and clinical changes. Brain Res. 805:1998;259-262
4. Eberling J.L., Pivirotto P., et al. Tremor is associated with PET measures of nigrostriatal dopamine function in MPTP-lesioned monkeys. Exp. Neurol. 165:2000;342-346
5. Eberling J.L., Cunningham J., et al. In vivo PET imaging of gene expression in Parkinsonian Monkeys. Mol. Ther. 8:2003;873-875
6. 18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods. J. Cereb. Blood Flow Metab. 13:1993;57-69
7. 18F]fluoro-L-m-tyrosine: metabolism, PET kinetics, and MPTP lesions in primates. Brain Res. 750:1997;264-276
8. Klein G.J., Teng X., et al. A methodology for specifying PET volumes-of-interest using multi-modality techniques. IEEE Trans. Med. Imaging. 16:1997;405-415
9. 18F]fluoro-L-m- tyrosine: an l-3,4-dihydroxyphenylalanine analog for probing presynaptic dopaminergic function with positron emission tomography. J. Neurochem. 53:1989;311-314
10. 18F]dopa PET. J. Neurol., Neurosurg. Psychiatry. 64:1998;314-319
11. 18F]6-fluoro- L-m-tyrosine in the human brain. Mov. Disord. 10:1995;298-304
12. Oiwa Y., Eberling J.L., et al. Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes. Front. Biosci. 8:2003;A155-A166
13. Vingerhoets F.J., Schulzer M., et al. Reproducibility and discriminating ability of fluorine-18-6-fluoro-L-dopa PET in Parkinson's disease. J. Nucl. Med. 37:1996;421-426
14. Wienhard K., Dahlbom M., et al. The ECAT EXACT HR: performance of a new high resolution positron scanner. J. Comput. Assist. Tomogr. 18:1994;110-118